IP Library › Granted Patent US 10,978,277
Granted Patent B2
US 10,978,277 · App. 15/572,454 · Granted Apr 13, 2021

Apparatus and method for handling an implant

Inventors: Amnon Lam (Kibbutz Givat Oz, IL); Aviad Harhol (Tel Aviv, IL); Eliezer Fuchs (Kibbutz Megiddo, IL); Chen Porat (Kiryat Tivon, IL)
Assignee: NOVA PLASMA LTD.
H01J37/32798A61L27/18A61L27/50A61L27/54H01J37/321H01J37/32403H01J37/32449H01J37/32568H01J37/32715H01J37/32733H01J37/32825A61L2300/406A61L2400/18A61L2430/04H01J37/32091H01J37/32348
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,978,277
App. No.
15/572,454
Granted
Apr 13, 2021
Kind
B2
Abstract

An apparatus for plasma treatment of an implant prior to installing the implant in a live subject is provided. The apparatus comprises an activation device and a portable container detachable from the activation device. The portable container comprises a closed compartment containing the implant immersed in a fluid, and the activation device comprises a slot configured to receive the portable container. The activation device further comprises an electrical circuit configured to be electrically associated with at least one electrode and configured to provide to the at least one electrode electric power suitable for applying a plasma generating electric field in the closed compartment, when the portable container is disposed in the slot. A container suitable for providing plasma treatment to a silicone implant and a method for preparing an implant for implantation surgery are also provided.

Claims (29)

1. A method for preparing a silicone implant for implantation into in a live subject, the method comprising:

generating plasma in a plasma chamber housing the implant;

after said generating plasma and prior to removing the implant from the plasma chamber, wetting the implant with a polar liquid; and

after said wetting, removing the implant from the plasma chamber, for installing the implant in the live subject.

2. The method of claim 1 wherein said polar liquid includes at least one therapeutically effective agent.

3. The method of claim 2 wherein said polar liquid is water.

4. The method of claim 2 wherein said at least one therapeutically effective agent is selected from the group consisting of antimicrobial agents, anesthetics, analgesics, anti-inflammatory agents, anti-scarring agents, anti-fibrotic agents, anti- cancer compounds, hemostatic material for controlling bleeding, hormone therapeutics, stem cells, and cellular precursors.

5. The method of claim 1 , further comprising evacuating the plasma chamber prior to said generating plasma.

6. The method of claim 1 , further comprising flushing the plasma chamber with an inert gas during said plasma generation.

7. The method of claim 1 wherein the implant includes a breast implant.

8. The method of claim 7 wherein plasma is generated by a plasma-generating EM field applied by pairs of electrodes, the pairs of electrodes being supplied with electric power sequentially.

9. A method for preparing a silicone implant for implantation into a live subject, the method comprising:

generating plasma in a plasma chamber housing the implant without introducing coating material into the plasma chamber;

after said generating plasma, wetting the implant with a polar liquid; and

after said generating plasma, removing the implant from the plasma chamber, for installing the implant in the live subject.

10. The method of claim 9 wherein said polar liquid comprises at least one therapeutically effective agent.

11. The method of claim 10 wherein said at least one therapeutically effective agent includes at least one of antimicrobial agents, anesthetics, analgesics, anti-inflammatory agents, anti-scarring agents, anti-fibrotic agents, anti-cancer compounds, hemostatic material for controlling bleeding, hormone therapeutics, stem cells, or cellular precursors.

12. The method of claim 9 wherein said wetting is performed prior to said removing the implant from the plasma chamber.

13. The method of claim 9 wherein said removing the implant from the plasma chamber is performed prior to said wetting.

14. The method of claim 9 wherein the implant includes a breast implant.

15. A method for preparing a silicone implant for implantation into a live subject, the method comprising:

in a plasma chamber housing the implant, generating plasma in a space adjoining the implant, thereby increasing the implant's surface tension to 0.072 N/m or more;

after said generating plasma, wetting the implant with a polar liquid; and

after said generating plasma, removing the implant from the plasma chamber, for installing the implant in the live subject.

16. The method of claim 15 wherein said wetting is performed prior to said removing the implant from the plasma chamber.

17. The method of claim 15 wherein said removing the implant from the plasma chamber is performed prior to said wetting.

18. The method of claim 15 wherein said polar liquid is water.

19. The method of claim 15 further comprising flushing the plasma chamber with an inert gas during said plasma generation.

20. The method of claim 15 wherein the implant includes a breast implant.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 7, 2017
From: LAM, AMNON; HARHOL, AVIAD; FUCHS, ELIEZER; PORAT, CHEN
To: NOVA PLASMA LTD.
Reel/Frame 044058/0051 →
Continuity (4)
Provisional Application 62159387 · May 11, 2015
Provisional Application 62239928 · Oct 11, 2015
Provisional Application 62300942 · Feb 29, 2016
Related Publication 20180138022A1 · May 17, 2018